MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • MDS Virtual Congress 2020

    Nucleus basalis of Meynert free-water distinguishes and predicts cognitive impairment and longitudinally correlates with cognitive changes in early Parkinson’s disease

    T. Guttuso, Jr., D. Tosun, R. Zivadinov, O. Pasternak, D. Weintraub, N. Bergsland (Buffalo, NY, USA)

    Objective: To explore diffusion-based MRI assessments of the nucleus basalis of Meynert (nbM) as a neuroimaging biomarker of cognitive abilities and longitudinal cognitive changes in…
  • MDS Virtual Congress 2020

    Iron Imaging as a Diagnostic Tool for Parkinson’s Disease: A Systematic Review and Meta-Analysis

    N. Pyatigorskaya, C. Sanz Morere, R. Gaurav, E. Biondetti, R. Valabregue, M. Santin, L. Yahia-Cherif, S. Lehericy (Paris, France)

    Objective: We performed a systematic meta-analysis of SN iron imaging studies in PD to better understand the role of iron-sensitive MRI quantification to distinguish patients…
  • MDS Virtual Congress 2020

    Automated classification of neurodegenerative parkinsonian syndromes using multimodal magnetic resonance imaging in a clinical setting

    L. Chougar, J. Faouzi, N. Pyatigorskaya, O. Colliot, S. Lehéricy (Paris, France)

    Objective: To evaluate the accuracy for the categorization of parkinsonian syndromes of a machine learning algorithm trained with a research cohort and tested on an…
  • MDS Virtual Congress 2020

    Tau Neuropathology Associates with In Vivo Patterns of Neurodegeneration in Lewy Body Disorders

    N. Spotorno, D. Coughlin, L. Shaw, A. Chen-Plotkin, D. Weintraub, E. Lee, J. Trojanowski, C. McMillan, D. Irwin, M. Grossman (Philadelphia, PA, USA)

    Objective: Investigate the impact of Alzheimer’s disease (AD) co-pathology on an in vivo structural measure of neurodegeneration in Lewy Body disorders (LBD: Parkinson’s Disease and…
  • MDS Virtual Congress 2020

    Impaired Structural Connectivity in Parkinson’s Disease and its Neuropsychological Correlates

    A. Inguanzo, R. Sala-Llonch, C. Junque, A. Abos, A. Campabadal, C. Uribe, H. Baggio, Y. Compta, M. Marti, F. Valldeoriola, B. Segura (Barcelona, Spain)

    Objective: The aim of this study was to detect disrupted structural connectivity in Parkinson's disease (PD) patients classified according to their cognitive status, with and…
  • MDS Virtual Congress 2020

    Association Between Ventricle/Brain Volumes and Mobility Metrics in Parkinson’s Disease

    A. Ragothaman, A. Giritharan, M. Mancini, O. Miranda-Dominguez, D. Fair, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To investigate the relationship between brain ventricular and gray matter volumes and objective balance and gait metrics in people with Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2020

    Morphology and Signal Changes of the Lentiform Nucleus Based on Susceptibility Weighted Imaging in Parkinsonism predominant Multiple System Atrophy

    C.P Zhao, Q.G Ren (Qindao, China)

    Objective: This present case-control study was aimed to investigate both morphological and signal intensity changes in susceptibility weighted imaging(SWI) of the Lentiform Nucleus (LN) for…
  • MDS Virtual Congress 2020

    Convolutional neural network for discriminating between Multiple System Atrophy and Healthy Control, comparing MRI modalities and highlighting the disease signature

    E. Villain, F. Nemmi, A. Pavy-Le Traon, W. Meissner, O. Rascol, M.V Le Lann, X. Franceries, P. Péran (Toulouse, France)

    Objective: To develop a neural network architecture based on multimodal MRI brain imaging to discriminate between multiple system atrophy (MSA) and healthy controls (HC), and…
  • MDS Virtual Congress 2020

    Elevated nigral iron is associated with low plasma serotonin in Parkinson’s disease

    L. Jellen, A. Snyder, G. Du, M. Lewis, E. Wang, C. Capan, P. Brundin, L. Brundin, J. Connor, X. Huang (Hershey, PA, USA)

    Objective: The objective of this work was to determine whether plasma serotonin levels in Parkinson’s disease (PD) are related to iron levels in the brain,…
  • MDS Virtual Congress 2020

    Application of substantia nigra feature extraction in the progression of Parkinson’s disease based on magnitude image of susceptibility weighted imaging

    Q. Ren, B. Zhang, J. Zhang, X. Shuai, X. Nan, Y. Ge, X. Meng, C. Zhao (Qingdao, China)

    Objective: This present study was aimed to investigate the potential value of the substantia nigra (SN) radiomic feature for the prediction of PD progression. Background:…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 72
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley